For biopharmaceutical manufacturers, selecting the right cell culture media—critical for growing cells—can be challenging.
They require media that will suit the needs of specific cell lines and will deliver the most robust product yield, quality and consistency.
We’re making this selection process a whole lot easier with our new Cellvento™ CHO platform of cell culture media and companion feeds, which deliver superior cell growth and productivity for various CHO* cell types used in biopharmaceutical development and manufacturing.
The chemically defined, non-animal-origin media are available in powder and liquid form for use in batch, fed-batch and perfusion applications. “The Cellvento™ CHO platform offers a variety of formulations, all backed by Merck’s strong chemical, raw material and regulatory expertise. This range of options ensures customers have the flexibility to select the best media for their specific process, optimizing their production and ultimately accelerating time to market.”
— Andrew Bulpin, Executive VP, Merck Process Solutions Business Area
To learn more about the advantages of the Cellvento™ CHO platform, please visit: www.merckmillipore.com/cellvento
* CHO: Chinese hamster ovary cells, widely used to produce recombinant proteins, such as monoclonal antibodies,
in the pharmaceutical industry.